Sex: M
Vaccine: SMALLMNK
Symptoms: Incorrect dose administered, No adverse event, Product administered to patient of inappropriate age
Clinical narrative: 0.1 mL of Jynneos administered intradermally; 17 year old patient received Jynneos vaccine; Case reference number US-BN-2022-004542 is a spontaneous case report initially received on 04-Nov-2022 from other health professional via Communication (reference number: USBAV22-1862) and concerns a 17-year-old male patient.  The patient's medical history and concomitant medication details were not provided.  On 24-Sep-2022, the patient was vaccinated with the first dose of Jynneos vaccine (Smallpox and Monkeypox Vaccine, Live, Nonreplicating; batch number: FDP00003), at dose reported as 0,1 mL administered intradermally at an unknown site, for monkeypox prophylaxis. As reported, the patient was vaccinated with an adult dosage but since the patient was a minor, the smaller dose of vaccine 0,1 mL instead of 0,5 mL was administered intradermally (explicitly coded as 'intradermal injection' and 'inappropriate age at vaccine administration').  At the time of this report, it was unknown if the patient experienced any adverse event due to Jynneos vaccination.  Additional information received on 07-Nov-2022 from included the local ID number.  This case is linked to case US-BN-2022-004544 (same reporter).; Reporter's Comments: A 17-year-old male patient was vaccinated with the first dose of Jynneos, at dose reported as 0,1 mL administered intradermally at an unknown site, for monkeypox prophylaxis. Reportedly, the patient was vaccinated with an adult dosage but since the patient was a minor, the smaller dose of vaccine 0,1 mL instead of 0,5 mL was administered intradermally (considered as intradermal injection and inappropriate age at vaccine administration). Injection and product administered to patient of inappropriate age are both considered listed per company conventions. At this point, it was unknown if the patient experienced any adverse event due to Jynneos vaccination. The patient's medical history and concomitant medication details were not provided. Injection and product administered to patient of inappropriate age are both assessed as not related to suspect product but to human factor. The case is non-serious.; Sender's Comments: A 17-year-old male patient was vaccinated with the first dose of Jynneos, at dose reported as 0,1 mL administered intradermally at an unknown site, for monkeypox prophylaxis. Reportedly, the patient was vaccinated with an adult dosage but since the patient was a minor, the smaller dose of vaccine 0,1 mL instead of 0,5 mL was administered intradermally (considered as intradermal injection and inappropriate age at vaccine administration). Injection and product administered to patient of inappropriate age are both considered listed per company conventions. At this point, it was unknown if the patient experienced any adverse event due to Jynneos vaccination. The patient's medical history and concomitant medication details were not provided. Injection and product administered to patient of inappropriate age are both assessed as not related to suspect product but to human factor. The case is non-serious.